ABSTRACT Measurement of the urinary folate catabolites, para-aminobenzoylglutamate (pABG) and the more predominant acetylated form, acetamidobenzoylglutamate (apABG), has been used to assess folate requirements in both pregnant and nonpregnant women. Folate catabolite excretion has been reported to be significantly higher in pregnant women (second trimester) compared with nonpregnant controls. The primary goals of this study were to determine if pregnant women in a controlled metabolic study excreted higher quantities of urinary folate catabolites than nonpregnant controls and if catabolite excretion was influenced by folate intake. We evaluated the effect of gestation and folate intake on the urinary excretion of apABG and pABG in pregnant women (n Å 12; wk 14-26 gestation) and nonpregnant controls (n Å 12) assigned to consume folate levels approximating the current (400 mg/d) and previous (800 mg/d) RDA. Subjects were fed a controlled diet containing 120 mg folate/d and either 330 or 730 mg synthetic folic acid/d. In contrast to previously reported data, no differences in mean folate catabolite excretion were detected between pregnant and nonpregnant subjects. Catabolite excretion (pABG / apABG) decreased significantly relative to initial values in pregnant women consuming 450 mg folate/d (040 { 20%; mean { SD) and final mean excretion was significantly lower in the pregnant women consuming 450 mg folate/d (86 { 32 nmol/d) compared with 850 mg folate/d (148 { 20 nmol/d). Data from this study indicate that second trimester pregnant women do not excrete more folate catabolites than nonpregnant controls and that consumption of 450 vs. 850 mg folate/d results in a significant reduction in the quantity of folate catabolites excreted.
Folate coenzymes are integral components of one carbon folate requirements have included increased need for folate coenzymes involved in cell division (Hibbard 1964) , malabmetabolism and are necessary for the synthesis of DNA, RNA sorption (Giles 1966) , increased urinary folate excretion and certain amino acids (Wagner 1995) . Pregnancy is associ- (Fleming 1972, Landon and Hytten 1971) , fetal drainage (Ek ated with an enormous increase in cellular proliferation due and Magnus 1981, Giles 1966) , and, most recently, increased to increased maternal erythropoiesis, maternal uterine and folate catabolism (McPartlin et al. 1993 ). mammary tissue growth as well as placental and fetal develop-
The finding that only 1-2% of folate intake is excreted as ment (Blackburn and Loper 1992, Cunningham et al. 1993) .
intact urinary folate suggests that folate is broken down before The increased demand for folate during pregnancy, often reurinary excretion (Jukes et al. 1947) . Studies conducted in sulting in compromised folate status, is well established (Bailey rats (Connor et al. 1979 , Murphy et al. 1976 , Scott et al. 1980 , Chanarin et al. 1968 , Colman et al. 1975 , Ek and and Gregory 1996 and humans (Blair 1957 , Krumdieck et al. Magnus 1981 , Lowenstein et al. 1966 , Qvist et al. 1986 , Pheasant et al. 1979 , Saleh et al. 1980 have confirmed is one of few nutrients for which the Recommended Dietary that the major route of whole body folate turnover is by cataboAllowance (RDA) 6 doubles from nonpregnant conditions lism and cleavage of the C9-N10 bond producing pteridines (NRC 1989) . During the past 60 y, explanations for the higher and para-aminobenzoylglutamate (pABG). Before excretion from the body, the majority of pABG is N-acetylated to acet- nonpregnant controls. They reported that pregnant women in 4 The costs of publication of this article were defrayed in part by the payment the second trimester excreted twice as much urinary apABG of page charges. This article must therefore be hereby marked ''advertisement'' in accordance with 18 USC section 1734 solely to indicate this fact.
as nonpregnant controls or pregnant women in the first trimes-5 To whom correspondence should be addressed.
ter. A modest increase in apABG excretion also was observed 6 Abbreviations used: apABG, acetamidobenzolyglutamate; NP, nonpregnant; in the third trimester. Recommended dietary allowances were NRC, National Research Council; P, pregnant; pABG, para-aminobenzoylglutamate; RDA, Recommended Dietary Allowance.
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FOLATE CATABOLISM DURING PREGNANCY beverages to achieve weight maintenance and weight gain in nonon the basis that the molecular weight of either catabolite is pregnant and pregnant subjects, respectively. served during the third trimester was hypothesized to represent Isolation and quantification of apABG and pABG. Urinary a change in the nature of growth from hyperplastic to hypertropABG and apABG were isolated and quantified by the method of phic (McPartlin et al. 1993) . The current RDA for pregnant McPartlin et al. (1992) with minor modifications. Urinary catabolites women is 400 mg folate/d (NRC 1989) , which was decreased were quantified in duplicate on a bimonthly basis in pregnant women by 50% from the former RDA of 800 mg folate/d (NRC 1980) . (weeks 0, 2, 4, 6, 8, 10 and 12) and on a monthly basis in nonpregnant
The work of McPartlin et al. (1993) Toth 1988, Selhub et al. 1980) . Because recovery tests indicated complete recovery of both point during each trimester.
pABG and apABG from the folate affinity columns, the radioactive
We examined the urinary excretion of pABG and apABG standards were added after this step. The effluent from the affinity in pregnant women (n Å 12) during their second trimester column was next separated into duplicate 20-mL portions to which and in nonpregnant controls (n Å 12) throughout a 12-wk [
MATERIALS AND METHODS
apABG was eluted and collected in 100 mL 0.6 mol/L HCl. The two pABG fractions were kept separate throughout the remainder of the The protocol was approved by the University of Florida's Institupurification and quantification process. The 100-mL fractions contional Review Board and informed consents were obtained from all taining pABG were derivatized by the method of Bratton and Marsubjects. Healthy pregnant subjects (n Å 12; 14-26 wk gestation;
shall (1939) . One milliliter of 5.0 mol/L HCl and 1 mL sodium nitrite 18-35 y) and nonpregnant controls (n Å 12; 18-35 y) were assigned solution (1%) were added to each sample and allowed to react for 5 randomly to folate intakes of either 450 or 850 mg/d (1020 or 1926 min at room temperature. Ammonium sulfamate solution (50 g/L; 1 nmol/d, respectively). Pregnant women participated in this study from mL) then was added to destroy excess HNO 2 . After 5 min, 1 mL Ntheir 14th to 26th wk of pregnancy; this represents the second trimes-(1-naphthyl)ethylenediamine solution (10 g/L) was added to couple ter (14-28 wk) as defined by Cunningham et al. (1993) . Gestational with pABG. The samples sat overnight at room temperature to allow age was determined by sonogram in conjunction with date of last complete formation of the purple-colored azo-N-(1-naphthyl)-ethylmenstrual period. Four experimental groups (n Å 6) were compared: enediamine derivative of pABG (azo-pABG). Each sample (Ç104 pregnant subjects fed either 450 or 850 mg folate/d and nonpregnant mL) was applied to a preactivated (5 mL methanol wash followed by subjects fed the same two levels. These intakes approximated the 5 mL H 2 O) C 18 Sep Pak cartridge (Waters, Milford, MA) under current (400 mg folate/d) and former (800 mg folate/d) RDA for negative pressure for further purification and concentration. After a pregnant women (NRC 1980 and 1989) . The diet consumed by all 10 mL 0.05 mol/L HCl wash, azo-pABG was eluted in 4 mL 100% participants consisted of conventional foods as described previously methanol. The solution was evaporated to dryness at 40ЊC under a (Caudill et al. 1997 ) and provided 120 { 15 mg folate/d. The remainstream of nitrogen. The residue was reconstituted in 250 mL H 2 O, der, either 330 or 730 mg folate/d, was provided as synthetic folic and pABG was regenerated upon addition of 25 mL HCl (5 mol/L) acid administered in apple juice and consumed with meals (Caudill and 25 ml zinc dust suspension (1 g/3 mL H 2 O). After 15 min of et al. 1997). Considering the higher bioavailability of synthetic folic intermittent mixing, the reaction mixture was transferred to a 1-mL acid consumed with food (Ç75%) relative to dietary folate (Ç50%), Eppendorf tube and centrifuged for 10 min. The supernatant was the two levels of intake equate to Ç600 and 1000 mg/d dietary equivaremoved, filtered to remove zinc particles and stored at 020ЊC before lents (Caudill et al. 1997 The amount of pABG (representing the two catabolites) in a Center, whereas lunch and snacks were consumed away from the sample was determined by reverse-phase HPLC under the following research center.
conditions: 100-mL injection volume, octadecylsilica column (UlThe body mass index (BMI) of pregnant (prepregnancy weights) tramex C 18 , 5-mm particle size; 4.6 mm I.D. x 250 mm; Phenomenex, and nonpregnant women was within normal range 19-26 kg/m 2 with Torrance, CA), flow rate 1.0 mL/min, isocratic mobile phase commeans { SD of 22 { 3 and 23 { 2 kg/m 2 , respectively. Energy intake posed of acetonitrile (2%) and 0.1 mol formic acid/L (98%), pH 4.0. was adjusted by manipulation of non-nutritive food items such as sweetened gelatin, margarine, candy and sweetened or unsweetened A UV absorption detector (Dionex AD20) monitoring at 280 nm was 
RESULTS
Urinary apABG. Initial (d1), final (d84) and percent change at the end of the 84-d experimental period from initial d1 measurement for apABG excretion in pregnant and nonpregnant women consuming either 450 or 850 mg folate/d are shown in Table 1 . No differences (P ú 0.05) were detected in initial means for any of the groups. Urinary apABG excretion decreased (P Å 0.059) over time at a rate of about 04.4 nmol/ wk in the pregnant women consuming 450 mg folate/d and resulted in significantly less (P°0.05) apABG excretion by differences were detected in final mean apABG excretion between nonpregnant women consuming 450 vs. 850 mg folate/d. No differences were detected in final means between pregnant with nonpregnant controls and experienced a rapid decline in pABG excretion during the first 2 wk of the study (Figure 2) . and nonpregnant groups regardless of level of supplementation.
Urinary pABG. Initial (d1), final (d84) and percent The excretion of pABG decreased significantly (P°0.05) over time at about 01.4 nmol/wk in pregnant subjects consumchange at the end of the 84-d experimental period from initial d1 measurement for pABG excretion in pregnant and nonpreging 450 mg folate/d and was less at the end of the experimental period than in the 850 mg folate/d pregnant group (Table 2) . nant women consuming either 450 or 850 mg folate/d are illustrated in Table 2 . Pregnant women assigned to consume
In contrast, no difference (P ú 0.05) in final mean pABG excretion was detected between nonpregnant women consum-850 mg folate/d excreted more pABG at baseline compared / 4w30$$3898 01-08-98 22:53:57 nutra LP: J Nut February ing 450 vs. 850 mg folate/d. No differences in final means were folate/d that was not observed in the 450 mg folate/d nonpregnant group. In addition, significant differences were detected detected between pregnant and nonpregnant women regardless of level of supplementation. Urinary pABG was correlated in final mean pABG excretion between pregnant women consuming 450 vs. 850 mg folate/d but not between the nonpregpositively with serum folate (r Å 0.42, P Å 0.04) and urinary 5-methyl-tetrahydrofolate (r Å 0.52; P Å 0.001) in contrast nant 450 or 850 mg folate/d groups. These findings suggest that pABG excretion is also affected by gestation during periods of to apABG, which was not significantly correlated with these indices.
lower intake (450 vs. 850 mg folate/d) and may be the result of reduced endogenous folate catabolism or less excretion of Urinary total pABG / apABG. The fact that pregnant women did not excrete higher quantities of folate catabolites intact folate, which could later degrade to pABG. Although our findings in pregnant women differed from relative to nonpregnant controls also was illustrated by the total urinary folate catabolite excretion (pABG / apABG) that repeated by McPartlin's group, agreement existed in catabolite values of nonpregnant women among this study and ( Table 3) . In contrast to an expected increase in folate catabolite excretion during the course of the second trimester, total those of McPartlin et al. (1993) and Kownacki-Brown et al. (1995) . The mean urinary apABG and pABG concentrations folate catabolite excretion significantly decreased over time in the pregnant subjects consuming 450 mg folate/d. in our study were Ç110 and 27 nmol/d, respectively, compared with Ç104 and 49 nmol/d, respectively, (McPartlin et al. 1993) and Ç150 nmol/d (apABG / pABG) before supple-DISCUSSION mentation (Kownacki-Brown et al. 1995) . The differences beThe urinary folate catabolites, pABG and the more predomtween our findings in apABG excretion during pregnancy and inant form apABG, were measured at numerous time points those of McPartlin et al. (1993) may have been influenced by throughout a 12-wk period during which time pregnant subthe differences in protocols. In the present study, folate intake jects in their second trimester (wk 14-26) and nonpregnant was highly controlled for a 12-wk period during which time controls had folate intakes of either 450 or 850 mg/d. The repeated 24-h urine collections were obtained. In contrast, primary focus was differences in initial and final mean catabofolate intake only was controlled for a 42-h period in the study lite excretion and changes in catabolite excretion with time.
by McPartlin et al. (1993) . Our results did not confirm the work of McPartlin et al.
The concept of deriving requirements based solely on catab-(1993), who reported a twofold higher urinary apABG excreolite excretion appears to be inappropriate during pregnancy. tion by pregnant women during the second trimester relative
In addition to the apparent ability of pregnant women to to nonpregnant controls. We found that pregnant women conconserve folate when intake is limited, other avenues of folate suming 450 mg folate/d experienced a decline in apABG excreloss or accretion should be considered. For example, red cell tion from baseline measurements (037.8 { 20.4%) that was production increases by 33% during pregnancy (Blackburn and not observed in the 450 mg folate/d nonpregnant group. AlLoper 1992), resulting in greater folate uptake by reticulocytes. though differences between pregnant and nonpregnant women This extra demand for folate will not be reflected in urinary consuming 450 mg folate/d were not detected in final group catabolite concentration. The doubling in uterus size may remeans, had the study continued or had the subject number quire more folate coenzymes of which the majority may be been larger, differences may have been observed. Significant recycled upon utilization and not degraded and excreted as differences were detected in final mean apABG excretion beurinary catabolites. The developing fetus drains maternal folate tween pregnant women consuming 450 vs. 850 mg folate/d, supplies as evidenced by the significantly higher plasma and and these differences were not detected between nonpregnant red cell folate concentrations in newborns compared with masubjects consuming these amounts. These data indicate that ternal concentrations (Ek and Magnus 1981, Giles 1966) . Fogestation is associated with a reduction in the urinary excretion late accumulated by the placenta and delivered to the develof apABG when folate intake is somewhat lower (i.e., 450 vs. oping fetus will not be estimated by measurement of maternal 850 mg/d) and suggests that pregnant women may be more folate catabolites. In addition, measurement of urinary cataboefficient at conserving folate than their nonpregnant counterlite excretion alone does not account for endogenous fecal parts. loss of intact folates or catabolites, which may be substantial A decline in the urinary excretion of pABG (049 { 25%) (Krumdieck et al. 1978) . also was observed for the pregnant women consuming 450 mg
In conclusion, these data indicate that urinary folate catabolite excretion does not increase during the second trimester of pregnancy and therefore cannot explain the increased re- 
